📣 VC round data is live. Check it out!

NN Valuation Multiples

Discover revenue and EBITDA valuation multiples for NN and similar public comparables like Harju Elekter, Onyx Healthcare, Klingelnberg, Emvision and more.

NN Overview

About NN

NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.


Founded

1993

HQ

United States

Employees

2.6K

Website

nninc.com

Financials (LTM)

Revenue: $432M
EBITDA: $51M

EV

$315M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

NN Financials

NN reported last 12-month revenue of $432M and EBITDA of $51M.

In the same LTM period, NN generated $71M in gross profit, $51M in EBITDA, and had net loss of ($30M).

Revenue (LTM)


NN P&L

In the most recent fiscal year, NN reported revenue of $422M and EBITDA of $49M.

NN is unprofitable as of last fiscal year, with gross margin of 14%, EBITDA margin of 12%, and net margin of (8%).

See analyst estimates for NN
LTMLast FY202320242025202620272028
Revenue$432M$422M$489M$464M$422M
Gross Profit$71M$59M$70M$69M$59M
Gross Margin16%14%14%15%14%
EBITDA$51M$49M$13M$21M$17M
EBITDA Margin12%12%3%4%4%
EBIT Margin0%(1%)(4%)(6%)(4%)
Net Profit($30M)($34M)($50M)($38M)($34M)
Net Margin(7%)(8%)(10%)(8%)(8%)
Net Debt—$148M———

Financial data powered by Morningstar, Inc.

NN Stock Performance

NN has current market cap of $123M, and enterprise value of $315M.

Market Cap Evolution


NN's stock price is $2.46.

NN share price increased by 6.0% in the last 30 days, and by 20.0% in the last year.

NN has an EPS (earnings per share) of $-0.68.

See more trading valuation data for NN
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$315M$123M0.2%6.0%62.9%20.0%$-0.68

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

NN Valuation Multiples

NN trades at 0.7x EV/Revenue multiple, and 6.2x EV/EBITDA.

See NTM and 2027E valuation multiples for NN

EV / Revenue (LTM)


NN Financial Valuation Multiples

As of May 4, 2026, NN has market cap of $123M and EV of $315M.

NN has a P/E ratio of (4.1x).

LTMLast FY202320242025202620272028
EV/Revenue0.7x0.7x0.6x0.7x0.7x
EV/EBITDA6.2x6.4x23.4x15.2x18.5x
EV/EBIT173.4x(146.9x)(14.5x)(11.4x)(16.7x)
EV/Gross Profit4.4x5.3x4.5x4.5x5.3x
P/E(4.1x)(3.6x)(2.5x)(3.2x)(3.6x)
EV/FCFn/m(79.2x)35.6x(43.5x)(43.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified NN Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

NN Margins & Growth Rates

NN grew revenue by 7% and EBITDA by 12% in the last fiscal year.

In the most recent fiscal year, NN reported gross margin of 14%, EBITDA margin of 12%, and net margin of (8%).

See estimated margins and future growth rates for NN

NN Margins

Last FY202420252026202720282029
Gross Margin14%15%14%18%
EBITDA Margin12%4%4%12%
EBIT Margin(1%)(6%)(4%)2%
Net Margin(8%)(8%)(8%)(5%)
FCF Margin(1%)(2%)(2%)1%

NN Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%(5%)(9%)7%
Gross Profit Growth38%(1%)(15%)38%
EBITDA Growth12%54%(18%)222%
EBIT Growth(544%)26%(31%)(150%)
Net Profit Growth(36%)(24%)(11%)(36%)
FCF Growth(212%)(182%)0%(162%)

Data powered by FactSet, Inc. and Morningstar, Inc.

NN Operational KPIs

NN's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.

NN's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

NN's Rule of X is 29% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for NN
LTMLast FY202320242025202620272028
Rule of 4018%19%———
Bessemer Rule of X28%29%———
Revenue per Employee—$0.2M———
Opex per Employee—$0.0M———
Opex to Revenue—19%19%21%19%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Harju Elekter0.8x—7.6x—
Onyx Healthcare2.9x—25.9x—
Klingelnberg0.3x—3.7x—
Emvision—29.5x—(19.2x)
CTEK1.6x1.5x8.5x8.1x
Treace Medical Concepts0.7x0.7x(37.0x)(32.3x)
Fonar1.0x—5.7x—
Paxman3.3x3.0x35.8x24.0x

This data is available for Pro users. Sign up to see all NN competitors and their valuation data.

Start Free Trial

NN M&A Activity

NN has acquired 8 companies to date.

Last acquisition by NN was on April 3rd 2018. NN acquired Paragon Medical for $375M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by NN

Paragon Medical
Bridgemedica
Precision Engineered Products
Caprock Enclosures
Description
Paragon Medical is a Pierceton, Indiana-headquartered designer and manufacturer of precision medical components and instruments for orthopedic, spinal, and cardiovascular applications. The company produces single-use and reusable instruments like ratcheting drivers, bone awls, and threaded handles, alongside implantable components including screws, plates, anchors, rods, and femoral stems. Paragon Medical supplies sterile cases, trays, and kitting services to device OEMs such as Zimmer Biomet and Stryker. Its Pierceton campus includes prototyping, CNC machining, injection molding, and sterilization validation capabilities for global medical device markets.
Bridgemedica is a Minneapolis-based medical device company offering end-to-end services from concept design to commercial manufacturing. Its capabilities include engineering, prototyping, regulatory filings, intellectual property assessment, and global distribution. Bridgemedica supports clients with modular turnkey solutions or phased engagements for orthopedic, diagnostic, and minimally invasive devices across domestic and offshore supply chains.
Precision Engineered Products is a global manufacturer of custom precision components for medical devices, electrical connectors, transportation parts, and aerospace assemblies. Headquartered in the United States, P.E.P. serves OEMs with machined and stamped solutions from facilities in Asia and North America.
Caprock Enclosures is a Texas-headquartered manufacturer of custom plastic enclosures for industrial electronics and telecommunications equipment. The company produces NEMA-rated polycarbonate and ABS housings with options for polycarbonate windows, hinges, and mounting brackets. Caprock Enclosures serves OEMs in oil and gas, utilities, and security sectors from its facility in Grand Prairie. Established in 2008, it offers accessories like cable glands and desiccant packs.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Fort Wayne, IN
Boston, MA
Attleboro, MA
Lubbock, TX
Deal Date3 Apr 201822 Feb 201817 Aug 20154 Jun 2015
Valuation$375M$15M$615Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all NN acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About NN

When was NN founded?NN was founded in 1993.
Where is NN headquartered?NN is headquartered in United States.
How many employees does NN have?As of today, NN has over 2K employees.
Who is the CEO of NN?NN's CEO is Harold C. Bevis.
Is NN publicly listed?Yes, NN is a public company listed on Nasdaq.
What is the stock symbol of NN?NN trades under NNBR ticker.
When did NN go public?NN went public in 1994.
Who are competitors of NN?NN main competitors include Harju Elekter, Onyx Healthcare, Klingelnberg, Emvision, CTEK, Treace Medical Concepts, Fonar, Paxman, Apyx Medical, Novem Group.
What is the current market cap of NN?NN's current market cap is $123M.
What is the current revenue of NN?NN's last 12 months revenue is $432M.
What is the current revenue growth of NN?NN revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of NN?Current revenue multiple of NN is 0.7x.
Is NN profitable?Yes, NN is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of NN?NN's last 12 months EBITDA is $51M.
What is NN's EBITDA margin?NN's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of NN?Current EBITDA multiple of NN is 6.2x.
What is the current FCF of NN?NN's last 12 months FCF is ($1M).
What is NN's FCF margin?NN's last 12 months FCF margin is (0%).
What is the current EV/FCF multiple of NN?Current FCF multiple of NN is (284.3x).
How many companies NN has acquired to date?As of May 2026, NN has acquired 8 companies.
What was the largest acquisition by NN?$615M acquisition of Precision Engineered Products on 17th August 2015 was the largest M&A NN has done to date.
What companies NN acquired?NN acquired Precision Engineered Products, Paragon Medical, Autocam Corporation, Bridgemedica, RFK Valjcici d.d. Konjic, Chelsea Grinding Co., Caprock Enclosures, and Caprock Manufacturing.
In how many companies NN has invested to date?NN hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to NN

Lists including NN

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial